Professional presentation of antigen by activated human T cells

Activated human T cells express class II molecules, but their capacity to present soluble antigens and stimulate T cells has been repeatedly questioned. Two lines of evidence indicate that T cells may indeed function as professional antigen‐presenting cells. First, T cells that have been recently activated can efficiently capture, process and present tetanus toxoid to class II‐restricted T cell clones. This capacity correlates with the rate of class II synthesis. Second, activated T cell clones express high levels of B7, are powerful stimulators in mixed lymphocyte reactions, and their stumulatory capacity is inhibited by soluble CTLA4 or anti‐B7 antibody. Furthermore, expression of B7 can be detected in vivo on T cells from biopsies of patients with liver disease. Presentation of soluble antigen by activated T cells may play a role in the amplification of the specific response, and possibly in immunopathological states.

[1]  A. Lanzavecchia,et al.  Expression and functional properties of mouse B7/BB1 using a fusion protein between mouse CTLA4 and human gamma 1. , 1993, Immunology.

[2]  L. Lanier,et al.  Functional expression of B7/BB1 on activated T lymphocytes , 1993, The Journal of experimental medicine.

[3]  D. Sansom,et al.  B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro , 1993, European journal of immunology.

[4]  P. Parren,et al.  Functional characterization of a novel anti‐B7 monoclonal antibody , 1992, European journal of immunology.

[5]  T. Saibara,et al.  Binding of T cell receptor to major histocompatibility complex class II‐peptide complexes at the single‐cell level results in the induction of antigen unresponsiveness (anergy) , 1992, European journal of immunology.

[6]  T. Wyss-Coray,et al.  Discrimination of human CD4 T cell clones based on their reactivity with antigen‐presenting T cells , 1992, European journal of immunology.

[7]  R. Lechler,et al.  Human T cells cannot act as autonomous antigen-presenting cells, but induce tolerance in antigen-specific and alloreactive responder cells , 1992, The Journal of experimental medicine.

[8]  A. Fattorossi,et al.  Presentation of superantigen by human T cell clones: A model of T‐T cell interaction , 1992, European journal of immunology.

[9]  G. Freeman,et al.  Early signaling defects in human T cells anergized by T cell presentation of autoantigen , 1992, The Journal of experimental medicine.

[10]  C. Peschle,et al.  Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes , 1992, The Journal of experimental medicine.

[11]  P. Cresswell Chemistry and functional role of the invariant chain. , 1992 .

[12]  H. Ploegh,et al.  Intracellular transport of MHC class II molecules. , 1992, Immunology today.

[13]  A. Lanzavecchia,et al.  Processed antigen binds to newly synthesized mhc class II molecules in antigen-specific B lymphocytes , 1991, Cell.

[14]  R. Germain,et al.  MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding , 1991, Nature.

[15]  D. Hafler,et al.  Presentation of autoantigen by human T cells. , 1991, Journal of immunology.

[16]  J. Lamb,et al.  Clonal analysis of differential lymphokine production in peptide and superantigen induced T cell anergy. , 1991, International immunology.

[17]  P. Linsley,et al.  Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation , 1991, The Journal of experimental medicine.

[18]  R. Steinman,et al.  The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.

[19]  J. Lamb,et al.  Induction of specific clonal anergy in human T lymphocytes by Staphylococcus aureus enterotoxins. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Timothy A. Springer,et al.  Adhesion receptors of the immune system , 1990, Nature.

[21]  A. Lanzavecchia,et al.  Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. , 1990, Annual review of immunology.

[22]  Antonio Lanzavecchia,et al.  Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells , 1989, European journal of immunology.

[23]  M. Bretscher,et al.  Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells [published erratum appears in J Cell Biol 1990 Mar;110(3):859] , 1989, The Journal of cell biology.

[24]  V. Barnaba,et al.  Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection. , 1989, Journal of immunology.

[25]  H. Davidson,et al.  Epitope-directed processing of specific antigen by B lymphocytes , 1989, The Journal of cell biology.

[26]  R. Siliciano,et al.  Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: Effect of HIV sequence variation and a mechanism for CD4+ cell depletion , 1988, Cell.

[27]  A. Lanzavecchia,et al.  T cells can present antigens such as HIV gp120 targeted to their own surface molecules , 1988, Nature.

[28]  V. Barnaba,et al.  Expression of class I and class II major histocompatibility complex antigens on human hepatocytes , 1988, Hepatology.

[29]  T. Springer,et al.  Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma production. , 1988, Journal of immunology.

[30]  B. Dörken,et al.  Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targets , 1988, The Journal of experimental medicine.

[31]  T. Olsson,et al.  HLA-DR antigen expression on T cells from cerebrospinal fluid in multiple sclerosis and aseptic meningo-encephalitis. , 1987, Clinical and experimental immunology.

[32]  P. Debré,et al.  Expression of MHC class II and Tac antigens on IL2-activated human T cell clones that can stimulate in MLR, AMLR, PLT and can present antigen. , 1986, Human immunology.

[33]  A. Fauci,et al.  Activated human T cells can present alloantigens but cannot present soluble antigens. , 1985, Cellular immunology.

[34]  D. R. Gamble,et al.  In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. , 1985, The New England journal of medicine.

[35]  J. Lamb,et al.  Essential requirement for major histocompatibility complex recognition in T-cell tolerance induction , 1984, Nature.

[36]  D. Doniach,et al.  ABERRANT EXPRESSION OF HLA-DR ANTIGEN ON THYROCYTES IN GRAVES' DISEASE: RELEVANCE FOR AUTOIMMUNITY , 1983, The Lancet.

[37]  J. Lamb,et al.  Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin , 1983, The Journal of experimental medicine.

[38]  P. Wernet,et al.  Alloactivated long‐term cultured human T lymphocytes express both HLA‐DR and SB antigens but lack lymphocyte stimulation capacity , 1982, European journal of immunology.

[39]  R. Winchester,et al.  Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells , 1979, The Journal of experimental medicine.